<DOC>
	<DOCNO>NCT00672685</DOCNO>
	<brief_summary>Epidemiological fundamental research carry recent year highlight role play omega-3 fatty acid process cognitive decline accompanies advance age Alzheimer 's disease . In addition , recognize year , follow several convergent study prevention cognitive decline , nutrition , physical exercise , cognitive training social activity play significant role maintenance cognitive faculty . At present , number epidemiological argument favour protective role factor take isolation . It postulate multi-domain intervention may potentiate protective role omega-3 fatty acid . The main objective study assess efficacy isolated supplementation omega-3 fatty acid , isolate multi-domain intervention ( nutrition , physical exercise , cognitive stimulation , social activity ) , combination change cognitive function frail elderly subject age 70 year old 3 year . Secondary objective : - To assess efficacy treatment strategy change functional capacity prevention dependency , - To study long-term safety tolerability V0137 , - To study compliance adhesion multi-domain intervention programme , Ancillary study : To assess impact intervention program brain metabolism FDG PET ( MAPT-NI : : impact multidomain intervention brain metabolism ( FDG-PET ) ) - To evaluate impact preventive strategy ( Omega-3 treatment multidomain intervention ) MAPT study brain atrophy ( MRI ) , - To evaluate presence density ß-amyloid MAPT subject use AV45 PET scan ( MAPT AV45 ) , - To determine sleep disorder early stage Alzheimer 's disease could predictive cognitive decline use diagnosis tool ( Mapt SLEEP ) - To evaluate impact omega-3 fatty acid body composition measure DXA scan ( MAPT-DXA )</brief_summary>
	<brief_title>Omega-3 Fatty Acids and/or Multi-domain Intervention Prevention Age-related Cognitive Decline</brief_title>
	<detailed_description>This multi-centre , randomised , placebo-controlled study parallel group 1680 frail elderly subject age 70 year , live home , monitor period 3 year . The subject randomise one follow 4 group : - Omega-3 group : 800 mg/day docosahexaenoic acid ( V0137CA nutritional supplement ) - Omega-3 + multi-domain intervention group : 800 mg/day docosahexaenoic acid ( V0137CA ) - Placebo + multi-domain intervention group - Placebo group The multi-domain intervention include train / information session follow 4 area : nutrition , physical activity , cognitive training social activity , preventive consultation . Selected subject present least one follow frailty criterion : - Loss one Instrumental Activity Daily Living ( IADL ) - Subjective memory complaint physician - Slow walking speed . Follow-up visit occur every six month 3 year dispense supplement compliance ( month 6 , 12 , 18 , 24 , 30 36 ) neuropsychological functional assessment ( month 6 , 12 , 24 , 36 ) .</detailed_description>
	<criteria>subject sex , age 70 year , subject least one follow frailty criterion : subjective memory complaint , express attend physician , inability perform one instrumental activity daily live , slow walk speed ≤ 0.77 m/s , i.e 5 second walk 4 meter . subject MMSE score great equal 24 , subject capable understanding protocol , comply requirement attend study visit , subject sufficient availability take part multidomain intervention programme , subject , opinion investigator , liable comply treatment study ; subject capable give write informed consent Covered health insurance system Criteria related disease : know presence dementia Alzheimer 's disease ( DSM IV criterion ) , deterioration global cognitive function ( MMSE &lt; 24 ) , dependency basic activity daily live ( ADL &lt; 6 ) , presence serious disease , could lifethreatening short term , history presence disease could compromise subject 's participation multidomain intervention session , Criteria relate treatment : take supplement contain omega3 ( apart food ) within past 6 month and/or take omega3 inclusion . Criteria related subject : visual hearing impairment incompatible performance and/or interpretation neuropsychological test , history presence previous pathology could , opinion investigator , interfere result study expose subject additional risk , subject deprive freedom administrative judicial decision , guardianship admit healthcare social institution , participation another clinical study previous month participation schedule study .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Cognitive decline</keyword>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>nutrition</keyword>
	<keyword>physical exercise</keyword>
	<keyword>cognitive training</keyword>
	<keyword>social activity</keyword>
	<keyword>frailty</keyword>
</DOC>